AzTrials
AzTrials

Cancer-Related ConditionNCT04300842

Quantifying Fatigue in Cancer Patients Using Smart Bracelet Devices

An observational study of Cancer-Related Condition, run by Taipei Medical University at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This project expects to enroll 60 cancer patients, 60 healthy people and their subjective-objective measurements on fatigue, stress, and total steps will be validated so that the information can be used in further care and improvement of life of quality of the patients. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
Conditions the study is for
Cancer-Related Condition
What is being tested?
smart bracelet
Type of treatment
Medical device
How many people
120 participants
Where
1 siteTaiwan
Study dates
22 Dec 2019to 26 Dec 2021
How long will I take part?
1 Week
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Cancer patients with some cancer treatment side effects. Healthy people compare with cancer patients who no cancer disease now.

Who may be able to join

  • Age ≧ 20 years old;
  • One group had a cancer diagnosis, one group no cancer diagnosis;
  • Can continuous wearing bracelet for 5 days or more

Who cannot join

  • Unclear and unable to answer the questionnaire

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Taipei Medical University

    Taipei, 110

Other trials in Taiwan

About this study

This project expects to enroll 60 cancer patients, 60 healthy people and their subjective-objective measurements on fatigue, stress, and total steps will be validated so that the information can be used in further care and improvement of life of quality of the patients.

Being tested
smart bracelet
Keywords
Cancer-related fatigue, smart bracelet device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • smart braceletDevice

    to measure the stress, fatigue, and activity.

Study groups in NCT04300842
Study groupRoleWhat they receive
Cancer patientThis project expects to enroll 60 cancer patients and their subjective-objective measurements on fatigue, stress, and total steps will be observed.
Receives: Device: smart bracelet
Healthy populationThis project expects to enroll 60 healthy population and their subjective-objective measurements on fatigue, stress, and total steps will be observed.
Receives: Device: smart bracelet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. fatigue

    Unit of measure: severity of fatigue level; measurement tool: Brief Fatigue Index

    Measured: over 5 days

  2. Heart Rate Variability (HRV) monitor

    Use a digital device to measure the heart rate variability and calculate the HRV data

    Measured: over 5 days

Secondary outcomes (4)
  1. Distress Thermometer(DT)

    a screening measure to identify and address psychological distress in individuals with cancer. a cutoff score of 3 on the DT to indicate patients with clinically elevated levels of distress.

    Measured: over 5 days

  2. Leeds Sleep Evaluation Questionnaire(LSEQ)

    To assess sleep quality, higher scores mean more disrupt sleep.

    Measured: over 5 days

  3. International Physical Activity Questionnaire(IPAQ)

    Life activity survey

    Measured: over 5 days

  4. Perceived Stress Scale (PSS)

    higher scores mean more stressful condition

    Measured: over 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2020
  2. Study start22 Dec 2019
  3. Primary completion26 Dec 2020 (estimated)
  4. Study completion26 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
120 participants (estimated)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT04300842
Sponsor's protocol ID
N201910036
Status last verified
Dec 2019
First submitted
22 Dec 2019
Last updated
9 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Cancer-Related Condition, run by Taipei Medical University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

fatigue (time frame: over 5 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in